By using this site, you agree to the Privacy Policy and Terms of Use.
Accept
Health Works CollectiveHealth Works CollectiveHealth Works Collective
  • Health
    • Mental Health
    Health
    Healthcare organizations are operating on slimmer profit margins than ever. One report in August showed that they are even lower than the beginning of the…
    Show More
    Top News
    benefits of using protein powder to build muscles
    Protein Powder for Muscle Mass: Everything You Need to Know
    December 12, 2021
    changes brought on by blockchain in healthcare
    Technology In The Healthcare Industry
    March 28, 2022
    What Does Core Body Temperature Say About Health?
    August 17, 2022
    Latest News
    Grounded Healing: A Natural Ally for Sustainable Healthcare Systems
    May 16, 2025
    Learn how to Renew your Medical Card in West Virginia
    May 16, 2025
    Choosing the Right Supplement Manufacturer for Your Brand
    May 1, 2025
    Engineering Temporary Hospitals for Extreme Weather
    April 24, 2025
  • Policy and Law
    • Global Healthcare
    • Medical Ethics
    Policy and Law
    Get the latest updates about Insurance policies and Laws in the Healthcare industry for different geographical locations.
    Show More
    Top News
    FDA Approves Diabetes Pill
    May 2, 2011
    Patient Gets Drunk on Hand Sanitizer
    June 20, 2011
    Cultivating Health Improvement
    July 20, 2011
    Latest News
    Building Smarter Care Teams: Aligning Roles, Structure, and Clinical Expertise
    May 18, 2025
    The Critical Role of Healthcare in Personal Injury Recovery: A Comprehensive Guide for Victims
    May 14, 2025
    The Backbone of Successful Trials: Clinical Data Management
    April 28, 2025
    Advancing Your Healthcare Career through Education and Specialization
    April 16, 2025
  • Medical Innovations
  • News
  • Wellness
  • Tech
Search
© 2023 HealthWorks Collective. All Rights Reserved.
Reading: Mobius Therapeutics Lands $3M for Eye Surgery Drug Kits
Share
Notification Show More
Font ResizerAa
Health Works CollectiveHealth Works Collective
Font ResizerAa
Search
Follow US
  • About
  • Contact
  • Privacy
© 2023 HealthWorks Collective. All Rights Reserved.
Health Works Collective > Business > Finance > Mobius Therapeutics Lands $3M for Eye Surgery Drug Kits
BusinessFinance

Mobius Therapeutics Lands $3M for Eye Surgery Drug Kits

Deanna Pogorelc
Last updated: October 13, 2013 8:00 am
Deanna Pogorelc
Share
2 Min Read
SHARE

eye surgery drug kitsFirst published on MedCityNews.com. Now that it’s gotten some sales traction and a fresh round of capital, Mobius Therapeutics is ready to double its sales forceeye surgery drug kitsFirst published on MedCityNews.com. Now that it’s gotten some sales traction and a fresh round of capital, Mobius Therapeutics is ready to double its sales force and ramp up education efforts for Mitosol, its first product for eye surgeons.

What Mobius has done is take the drug mitomycin c, which ophthalmologists have been using for years off-label, and package it into a standard dosage kit that can be stored at room temperature for up to 24 months. The FDA has approved the kit for use in glaucoma surgery, and Mobius is pursuing additional applications in two other kinds of eye procedures.

St. Louis-based Cultivation Capital has just led a $3 million Series B for the company to support its expansion efforts.

“Having achieved critical regulatory, commercial, and market milestones, this investment will allow Mobius to accelerate the adoption of Mitosol, thereby improving convenience, occupational safety, consistency of patient treatment, and economics for patients, providers, and ophthalmologists,” Mobius President and CEO Ed Timm said in a statement.

More Read

Healthcare Customer Service
How Customer Service Is Your Best Physican Marketing Tool
Collaborating for Population Health Management Strategy
Rising Healthcare Cuts Raises the Debate for Private Care in the U.K.
FDA’s Farm Animal Antibiotics Ban Ignored Since 1977, Courts Say
Lessons on Transparency, “Sexy Science” and Compelling Business Cases

Glaucoma is one of the most common causes of blindness in the U.S. Medicines and surgeries are used to slow the progression of the disease by reducing pressure in the eyes.

Mitomycin c, which was initially introduced to the market as a chemotherapeutic agent, is used during surgery to prevent scarring that can block the drainage holes formed during surgery.

The St. Louis company last raised money in the fall of last year. Since then, it’s also received a payment indicator from CMS.

TAGGED:health start-ups!Mobius Therapeutics
Share This Article
Facebook Copy Link Print
Share

Stay Connected

1.5kFollowersLike
4.5kFollowersFollow
2.8kFollowersPin
136kSubscribersSubscribe

Latest News

Do You Grind Your Teeth at Night? Here’s How Night Guards and TMJ Treatments Can Help
Do You Grind Your Teeth at Night? Here’s How Night Guards and TMJ Treatments Can Help
Dental health
May 21, 2025
The Secret To A Confident Smile: Top Tips For Better Teeth
The Secret To A Confident Smile: Top Tips For Better Teeth
Dental health
May 21, 2025
Clinical Expertise
Building Smarter Care Teams: Aligning Roles, Structure, and Clinical Expertise
Health care
May 18, 2025
Grounded Healing: A Natural Ally for Sustainable Healthcare Systems
Grounded Healing: A Natural Ally for Sustainable Healthcare Systems
Health
May 15, 2025

You Might also Like

Healthcare Interview with Steve Grossman, Candidate for Governor of MA

March 14, 2014

Ablation Technologies in Liver Cancer

November 29, 2011
ACA health reform
BusinessHealth ReformHospital AdministrationPolicy & LawPublic Health

Health Reform Beyond the ACA: Are We Inching Towards Consensus?

October 27, 2013

Medicare Data Access Provides Payment Transparency

April 11, 2011
Subscribe
Subscribe to our newsletter to get our newest articles instantly!
Follow US
© 2008-2025 HealthWorks Collective. All Rights Reserved.
  • About
  • Contact
  • Privacy
Welcome Back!

Sign in to your account

Username or Email Address
Password

Lost your password?